Titlebook: Best Practices of Apheresis in Hematopoietic Cell Transplantation; Syed A. Abutalib,Anand Padmanabhan,Nina Worel Book 2020 Springer Nature

小巷

書目名稱Best Practices of Apheresis in Hematopoietic Cell Transplantation影響因子(影響力)




書目名稱Best Practices of Apheresis in Hematopoietic Cell Transplantation影響因子(影響力)學(xué)科排名




書目名稱Best Practices of Apheresis in Hematopoietic Cell Transplantation網(wǎng)絡(luò)公開度




書目名稱Best Practices of Apheresis in Hematopoietic Cell Transplantation網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Best Practices of Apheresis in Hematopoietic Cell Transplantation被引頻次




書目名稱Best Practices of Apheresis in Hematopoietic Cell Transplantation被引頻次學(xué)科排名




書目名稱Best Practices of Apheresis in Hematopoietic Cell Transplantation年度引用




書目名稱Best Practices of Apheresis in Hematopoietic Cell Transplantation年度引用學(xué)科排名




書目名稱Best Practices of Apheresis in Hematopoietic Cell Transplantation讀者反饋




書目名稱Best Practices of Apheresis in Hematopoietic Cell Transplantation讀者反饋學(xué)科排名

ANNUL

Advances and Controversies in Hematopoietic Transplantation and Cell Therapyhttp://image.papertrans.cn/b/image/184236.jpg

芳香一點(diǎn)

Buttress

Springer Nature Switzerland AG 2020

A簡潔的

packet

Introduction and Rationale,With great pleasure, we present this inaugural edition of . as part of the handbook series on .. This project is a collaborative effort that spanned a time period of more than 2?years and included more than 20 experts, many whom are national leaders in their respected fields.

Crater

Yann Desfougères,Adolfo Saiarditransplantation process. Apheresis facilities, which collect such cells, are integral part of this process, which includes its highly regulated arena. Many regulations and accreditations exist for this process with whom apheresis facilities should be familiar. The chapter provides an overview of the

飛來飛去真休

harangue

Hongying Lin,Karsten Lindner,Georg W. Mayra donor, and ensuring that the product is without additional risk to the recipient, continues to be of paramount importance. The evaluation of the donor’s medical eligibility and suitability is designed to identify and limit the risk of transmitting infectious, genetic, or neoplastic diseases to the

600

Hongying Lin,Karsten Lindner,Georg W. Mayrological diseases. Common strategies for peripheral blood CD34. cell mobilization include the use of hematopoietic growth factors alone or in combination with chemotherapy, resulting in a marked increase of CD34. cells in the peripheral blood. However, a significant proportion of patients fail to mo